Meeder Asset Management Inc Homology Medicines, Inc. Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$12.07 - $19.34 $2,329 - $3,732	-193 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$12.5 - $22.04 $2,412 - $4,253	193 New	193 $3,000
Q2 2019 Aug 05, 2019	SELL	$18.35 - $30.34 $3,504 - $5,794	-191 Closed	0 $0
Q1 2019 Apr 16, 2019	SELL	$19.76 - $29.57 $1,165 - $1,744	-59 Reduced 23.6%	191 $5,000
Q4 2018 Jan 17, 2019	BUY	$18.39 - $26.3 $4,597 - $6,575	250 New	250 $5,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.